Afatinib as Cancer Therapy for Exocrine Pancreatic Tumours

Clinical trial NCT01728818 · UNKNOWN

Trial details

NCT number: NCT01728818
Sponsor: PD Dr. med. Volker Heinemann
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Focus of Study Instead

Start date: 2013-04-01
Primary completion: 2017-01-01
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.